30923

30923
Anker SD, Butler J, Filippatos G, et al. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial. Circulation 2021; 143(4):337-49. DOI: 10.1161/CIRCULATIONAHA.120.051824. http://www.ncbi.nlm.nih.gov/pubmed/33175585
Einstellungen
30923
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 26.08.2021 | 11:32 Uhr